CERNOSTICS is developing technologies that will redefine the way cancer is identified, diagnosed, and treated. The company utilizes a complex integration of quantitative pathology and advanced informatics, supported by a robust electronic medical record management system. Cernostics personalizes cancer diagnosis and treatment by evaluating patient tissue samples using multiplexed florescence microscopy and imaging technology. These approaches hold great potential to produce better, safer, and more cost-effective results.